- Home
- ALF vs CVRX Comparison
ALF vs CVRX Comparison
Compare ALF & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALF
- CVRX
- Stock Information
- Founded
- ALF 2024
- CVRX 2000
- Country
- ALF United States
- CVRX United States
- Employees
- ALF N/A
- CVRX N/A
- Industry
- ALF
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALF
- CVRX Health Care
- Exchange
- ALF NYSE
- CVRX Nasdaq
- Market Cap
- ALF 370.1M
- CVRX 419.8M
- IPO Year
- ALF 2024
- CVRX 2021
- Fundamental
- Price
- ALF $10.42
- CVRX $4.77
- Analyst Decision
- ALF
- CVRX Buy
- Analyst Count
- ALF 0
- CVRX 7
- Target Price
- ALF N/A
- CVRX $14.50
- AVG Volume (30 Days)
- ALF 140.4K
- CVRX 370.8K
- Earning Date
- ALF 01-01-0001
- CVRX 05-08-2025
- Dividend Yield
- ALF N/A
- CVRX N/A
- EPS Growth
- ALF N/A
- CVRX N/A
- EPS
- ALF N/A
- CVRX N/A
- Revenue
- ALF N/A
- CVRX $52,870,000.00
- Revenue This Year
- ALF N/A
- CVRX $22.17
- Revenue Next Year
- ALF N/A
- CVRX $24.02
- P/E Ratio
- ALF $43.77
- CVRX N/A
- Revenue Growth
- ALF N/A
- CVRX 25.62
- 52 Week Low
- ALF $9.96
- CVRX $5.81
- 52 Week High
- ALF $10.39
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- ALF N/A
- CVRX 28.07
- Support Level
- ALF N/A
- CVRX $7.30
- Resistance Level
- ALF N/A
- CVRX $7.91
- Average True Range (ATR)
- ALF 0.00
- CVRX 0.56
- MACD
- ALF 0.00
- CVRX 0.12
- Stochastic Oscillator
- ALF 0.00
- CVRX 4.36
About ALF CENTURION ACQUISITION CORP
Centurion Acquisition Corp is a blank check company.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.